id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0104-0003,FDA,FDA-2001-N-0104,"Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Fast Track Drug Development Programs-
Designation, Development, and Application Review",Notice,Notice of Approval,2002-07-10T04:00:00Z,2002,7,,,2025-02-03T20:16:59Z,02-17073,0,0,09000064804baed2
FDA-2001-N-0104-0002,FDA,FDA-2001-N-0104,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review",Notice,30 Day Proposed Information Collection,2002-03-27T05:00:00Z,2002,3,2002-03-27T05:00:00Z,2002-04-27T03:59:59Z,2025-02-03T20:10:25Z,02-7375,0,0,09000064804baece
FDA-2001-N-0104-0001,FDA,FDA-2001-N-0104,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review",Notice,60 Day Proposed Information Collection,2001-10-23T04:00:00Z,2001,10,2001-10-23T04:00:00Z,2001-12-25T04:59:59Z,2025-02-03T20:03:20Z,01-26575,0,0,09000064804bae60